J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

imatinib mesylate mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

122 API Suppliers, 35 USDMF, 22 CEP/COS, 8 JDMF, 18 EU WC, 31 KDMF, 20 NDC API, 63 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

54 Intermediate Suppliers

54 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

579 FDF Dossiers, 37 FDA Orange Book, 101 Europe, 20 Canada, 352 Australia, 17 South Africa, 52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 15 SPI Pharma, 12 DKSH, 4 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 17 BASF, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 32 Disintegrants & Superdisintegrants, 31 Direct Compression, 28 Controlled & Modified Release, 22 Granulation, 22 Thickeners and Stabilizers, 19 Lubricants & Glidants, 17 Co-Processed Excipients, 16 Chewable & Orodispersible Aids, 14 Taste Masking, 14 Solubilizers, 12 Topical, 11 Film Formers & Plasticizers, 8 Parenteral, 5 API Stability Enhancers, 5 Emulsifying Agents, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

154 News #PharmaBuzz

154 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 43 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

24 APIs, 15 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/06/2025	Acebright India Pharma Private Limited	India	Alvogen Korea Co., Ltd.	Su522-2-ND	Imatinib mesylate	2019-06-27	Acebright (India) Pharma Private Limited	India	#116/117, KIADB Industrial Area, Jigani, Anekal, Taluk, Bangalore-560105, India
28/06/2025	Cdymax	India	Toru Corporation	No. 522-2-ND(A)	Imatinib mesylate	2023-02-16	Cdymax (India) Pharma Private Limited	India	#116/117, KIADB Industrial Area, Jigani, Anekal, Taluk, Bangalore-560105, India

Imatinib Mesylate Mesylate

imatinib mesylate mesylate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

122 API Suppliers

35 USDMF

22 CEP/COS

8 JDMF

18 EU WC

31 KDMF

20 NDC API

63 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

INTERMEDIATES

54 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

579 FDF Dossiers

37 FDA Orange Book

101 Europe

20 Canada

352 Australia

17 South Africa

52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE

TABLET;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Rochem International Inc

15 SPI Pharma

12 DKSH

4 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 ACG Worldwide

3 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

17 BASF

1 Clariant

10 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

1 Finar

9 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

2 Ingredion Pharma Solutions

33 Kerry

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

3 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

13 Roquette

6 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

3 Vasa Pharmachem